Microbix Biosystems Inc T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.

TSX:MBX - Post by User

Microbix Biosystems Inc > Cow-to-cow and from bird to cow...

<< Previous

Bullboard Posts

Next >>

Comment by prophetoffactzon Apr 04, 2024 12:19pm

97 Views

Post# 35970631

RE:RE:Cow-to-cow and from bird to cow...

@DeItaone

Bird flu pandemic could be ‘100 times worse’ than COVID, scientists warn “This virus [has been] on the top of the pandemic list for many, many years and probably decades,” Dr. Suresh Kuchipudi, a bird flu researcher from Pittsburgh, said at a recent panel discussing the issue, according to the Daily Mail. “And now we’re getting dangerously close to this virus potentially causing a pandemic.”

<< Previous

Bullboard Posts

Next >>

AI companies to invest in